Mankind Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Nov '24 Nov 22, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2019
Market Capitalization	1,022,330	921,654	-	-	-	-	Upgrade
Enterprise Value	982,128	902,241	-	-	-	-	Upgrade
Last Close Price	2551.60	2300.75	-	-	-	-	Upgrade
PE Ratio	48.42	48.18	-	-	-	-	Upgrade
Forward PE	45.11	43.88	-	-	-	-	Upgrade
PS Ratio	9.28	8.92	-	-	-	-	Upgrade
PB Ratio	9.68	9.62	-	-	-	-	Upgrade
P/TBV Ratio	11.32	12.00	-	-	-	-	Upgrade
P/FCF Ratio	51.13	50.17	-	-	-	-	Upgrade
P/OCF Ratio	43.48	42.82	-	-	-	-	Upgrade
PEG Ratio	2.74	1.91	-	-	-	-	Upgrade
EV/Sales Ratio	8.91	8.73	-	-	-	-	Upgrade
EV/EBITDA Ratio	35.72	35.57	-	-	-	-	Upgrade
EV/EBIT Ratio	42.15	41.93	-	-	-	-	Upgrade
EV/FCF Ratio	49.12	49.11	-	-	-	-	Upgrade
Debt / Equity Ratio	0.04	0.02	0.02	0.14	0.06	0.04	Upgrade
Debt / EBITDA Ratio	0.18	0.08	0.09	0.44	0.16	0.09	Upgrade
Debt / FCF Ratio	0.24	0.11	0.17	1.94	0.34	0.16	Upgrade
Asset Turnover	0.88	0.95	0.93	1.00	1.09	1.28	Upgrade
Inventory Turnover	2.09	2.18	1.84	1.69	1.77	2.23	Upgrade
Quick Ratio	2.07	2.02	1.14	0.65	1.78	1.32	Upgrade
Current Ratio	2.95	3.10	2.32	1.68	2.89	2.26	Upgrade
Return on Equity (ROE)	22.02%	22.58%	18.79%	25.99%	30.30%	31.75%	Upgrade
Return on Assets (ROA)	11.55%	12.41%	10.52%	14.76%	17.37%	20.01%	Upgrade
Return on Capital (ROIC)	14.42%	15.30%	13.24%	18.56%	22.22%	26.05%	Upgrade
Earnings Yield	2.07%	2.08%	-	-	-	-	Upgrade
FCF Yield	1.96%	1.99%	-	-	-	-	Upgrade
Payout Ratio	0.00%	-	-	-	-	29.35%	Upgrade
Buyback Yield / Dilution	-0.11%	-0.14%	-0.00%	-	-	-	Upgrade
Total Shareholder Return	-0.11%	-0.14%	-0.00%	-	-	-	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.